Jeffrey A. Meckler, Director at Cocrystal Pharma, Inc. (COCP), bought 75,000 shares at $0.46 ($34K) on 2014-12-11, disclosed to the SEC on 2014-12-15.
Open-market purchase of $34k COCP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.45 | 25,000 | $11K | 32.8% |
| 2 | $0.46 | 50,000 | $23K | 67.2% |
| Total | $0.46 avg | 75,000 | $34K | 100% |
| Filing → |
| TVTX | SELL | 2024-09-30 | $562K | — | Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |